Genzyme sends drug for rare cholesterol disorder to FDA
Genzyme sends drug for rare cholesterol disorder to FDA Bizjournals.com
View ArticleAegerion Pharma announces FDA acceptance of NDA for review of lomitapide
Aegerion Pharma announces FDA acceptance of NDA for review of lomitapide The Fly on the Wall
View ArticleFDA panel says lomitapide data supports 'appropriate use'
FDA panel says lomitapide data supports 'appropriate use' Yahoo/Fly on the Wall
View ArticleIsis Falls on Concerns Over Abnormal Growths With Kynamro
Isis Falls on Concerns Over Abnormal Growths With Kynamro Bloomberg
View ArticleIsis Pharma/Genzyme FDA Panel Live Blog
Isis Pharma/Genzyme FDA Panel Live Blog TheStreet.com
View ArticleProcessing Aegerion Pharmaceuticals' Recent Rally
Processing Aegerion Pharmaceuticals' Recent Rally Seeking Alpha
View ArticleAegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase...
Aegerion's Lomitapide - FDA Approval, Strong Launch, Stock Price Increase Anticipated Seeking Alpha
View ArticleGenzyme, Isis say CHMP adopts negative opinion on KYNAMRO
Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO Yahoo/Fly on the Wall
View ArticleAegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol...
Aegerion says FDA approves Juxtapid, a treatment for a rare high cholesterol disorder Yahoo/AP
View ArticleFDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia Comment...
FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia Forbes
View ArticleIsis: FDA Approval Of Kynamro Promises A Bright Future For Company
Isis: FDA Approval Of Kynamro Promises A Bright Future For Company Seeking Alpha
View ArticleAegerion reports results from Phase 3 study of Juxtapid
Aegerion reports results from Phase 3 study of Juxtapid Yahoo/Fly on the Wall
View Article
